Every health system holds a data asset of scientific and commercial value: years of imaging studies, reports, and surrounding clinical records. It reflects how care is delivered, which is what life sciences, device, and AI developers need.
Most health systems recognize this value. Far fewer have the strategy to realize it. The barrier is not ambition; it is the operational complexity of turning clinical data into research-grade data while protecting patients and the institution.
What a Data Strategy Requires
Putting clinical data to work externally is a standing capability with five moving parts:
- De-identification. Identifiers hide in headers, burned-in pixels, and narrative text. Removing these identifiers reliably, at scale, and to a regulatory standard is specialized work.
- Governance and compliance. HIPAA, institutional policy, institutional review board expectations, and state privacy law govern what can be shared with whom. Someone must own that framework.
- Data engineering. Raw DICOM, HL7, and FHIR data must be normalized, linked, and quality-checked before researchers can use it.
- Commercial operations. Finding qualified buyers, scoping requests, licensing, and fulfillment is a function most hospitals have never built.
- IT investment and resources. A data program competes for the infrastructure, budget, and engineering time clinical systems already demand.
Why Building It Alone Usually Stalls
Building this internally hits the same constraints: IT and informatics teams stretched across clinical priorities that rightly come first, legal and privacy functions built to protect the institution rather than run a data program, and no in-house real-world data commercial expertise. And one institution’s data, however rich, rarely reaches the scale or diversity researchers need, so the effort yields more risk than revenue.
What a Partner Changes
A data strategy partner takes on the responsibility, accountability, and workload of that capability so the hospital need not build it. The right partner:
- Carries the engineering, commercial, and fulfillment burden, with minimal lift on internal teams.
- Connects the institution to a broader network, so its patients are reflected in larger, more representative cohorts.
The outcome: new value, managed risk, and a real contribution to healthcare innovation, without new headcount or infrastructure.
Why OneMedNet
OneMedNet is the data strategy partner health systems can rely on to run their real-world data program from start to finish. Its iRWD™ platform and federated network of more than 2,300 healthcare partner sites, representing more than 90 million de-identified patient journeys and more than 270 million imaging studies, give partner hospitals the scale and market demand no single institution can generate alone. The result delivers value to the hospital and advances research that improves patient care.
Four things set the model apart:
- Source-level de-identification. Data is de-identified inside the provider’s environment, with a documented methodology.
- Multimodal depth. Imaging, reports, and structured clinical records are linked longitudinally for regulatory-grade, AI-ready research.
- Established demand. OneMedNet already serves life sciences, device, and AI developers, so partner data reaches qualified users from day one.
- A transparent partnership. Partners stay informed about how their de-identified data is used, the research it supports, and the impact it creates.